Biogen (BIIB) Minority Interest (2016 - 2023)
Historic Minority Interest for Biogen (BIIB) over the last 15 years, with Q3 2023 value amounting to -$4.1 million.
- Biogen's Minority Interest rose 5287.36% to -$4.1 million in Q3 2023 from the same period last year, while for Sep 2023 it was -$4.1 million, marking a year-over-year increase of 5287.36%. This contributed to the annual value of -$9.5 million for FY2022, which is 11496.06% down from last year.
- As of Q3 2023, Biogen's Minority Interest stood at -$4.1 million, which was up 5287.36% from -$6.4 million recorded in Q2 2023.
- In the past 5 years, Biogen's Minority Interest ranged from a high of $462.9 million in Q2 2021 and a low of -$21.6 million during Q1 2022
- Over the past 5 years, Biogen's median Minority Interest value was -$8.7 million (recorded in 2022), while the average stood at $42.8 million.
- Its Minority Interest has fluctuated over the past 5 years, first tumbled by 37560.98% in 2020, then soared by 332714.29% in 2021.
- Over the past 5 years, Biogen's Minority Interest (Quarter) stood at -$4.1 million in 2019, then plummeted by 246.34% to -$14.2 million in 2020, then soared by 547.18% to $63.5 million in 2021, then crashed by 114.96% to -$9.5 million in 2022, then surged by 56.84% to -$4.1 million in 2023.
- Its Minority Interest stands at -$4.1 million for Q3 2023, versus -$6.4 million for Q2 2023 and -$9.6 million for Q1 2023.